Q3 FY2026 · ended Sep 30, 2026 · Revenue $341.25M, +8.9% YoY · Filed Nov 5, 2026
Progyny, Inc. (PGNY) files with the SEC under industry code 8090, Services-Misc Health & Allied Services, NEC. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $341.3 million and net income of $26.3 million. Free cash flow was $47.2 million. As of Sep 30, 2026 it held $195.6 million in cash and investments and $25.9 million in total debt.
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- PGNY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1551306
- Former names
- Auxogyn, Inc. (until Mar 19, 2015); Auxogyn Inc (until Sep 16, 2013)
Other Services-Misc Health & Allied Services, NEC companies
- Fresenius Medical Care AG FMS
- Davita Inc. DVA
- Sotera Health Co SHC
- agilon health, inc. AGL
- Charming Medical Ltd MCTA
- Viemed Healthcare, Inc. VMD
- Park Dental Partners, Inc. PARK
- Marpai, Inc. MRAI
All 15 Services-Misc Health & Allied Services, NEC companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $341.3M | $350.5M | $328.5M | $318.4M | $313.3M |
| Operating income | $35.2M | $40.0M | $35.4M | $15.2M | $21.5M |
| Net income | $26.3M | $28.1M | $24.2M | $12.5M | $13.9M |
| Diluted EPS | $0.32 | $0.34 | $0.29 | $0.14 | $0.15 |
| Operating cash flow | $56.6M | $50.4M | $45.9M | $54.2M | $50.7M |
| Free cash flow | $47.2M | $44.2M | $39.6M | $48.6M | $46.0M |
| Total assets | $675.8M | $715.8M | $698.3M | $742.4M | $795.2M |
| Total liabilities | $261.8M | $262.6M | $259.0M | $226.4M | $235.2M |
| Stockholders' equity | $414.0M | $453.3M | $439.3M | $516.0M | $560.0M |
| Cash and investments | $195.6M | $236.9M | $225.1M | $310.1M | $345.2M |
| Total debt | $25.9M | $27.0M | $27.3M | $27.7M | $28.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 27, 2026 | May 21, 2026 |
| 8-K |
Current report
Other events
|
May 26, 2026 | May 26, 2026 |
All 937 Progyny, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.